Eye thickness study after cataract surgery
Part of Eyes & vision, Genetic & congenital clinical trials.
This study measures corneal thickness after cataract surgery in people with and without Fuchs' endothelial dystrophy (a condition that can cause cloudy vision). It may help doctors understand how the cornea heals after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older
- You are scheduled for cataract surgery
- You do not have other eye diseases like macular degeneration or glaucoma
- You have not had eye surgery or laser before
- You are not pregnant
- Your cornea is not too thick (less than 625 micrometers)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a scoring system to predict how well people with Fuchs dystrophy do after cataract surgery. It may help doctors plan better treatment for your cornea and lens.
This trial tests a special intraocular lens that works with a cornea transplant procedure (DMEK) for people who have both cataracts and Fuchs' endothelial corneal dystrophy. It aims to see if this lens improves vision and reduces the need for glasses.
This study compares two types of cataract surgery in people with Fuchs' dystrophy: one using a laser and the standard method. It looks at which approach gives better results for the cornea and vision.
This Phase 2 study tests whether eye drops containing a medicine called N-acetylcysteine (NAC) can reduce damaging “reactive oxygen” in people with advanced Fuchs’ endothelial corneal dystrophy (FECD). It involves people who need a special cornea transplant (DMEK) at the same time as cataract surgery, aiming to improve cornea healing and vision.
This study tests whether special eye drops (Rho-kinase inhibitors) can improve the health of the cornea in people who have both Fuchs endothelial corneal dystrophy and glaucoma. The drops may help reduce corneal swelling and preserve your vision.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
Hear when a new Fuchs Endothelial Corneal Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.